Corteva and partners agree to $455 million PFAS settlement with North Carolina

Chemours (CC), DuPont (DD), and Corteva (CTVA) settled PFAS-related litigation in North Carolina for $455 million. Chemours will pay $180 million, covered by existing accruals. The settlement resolves future escrow contributions and addresses remaining obligations, providing clarity for Chemours' operations. CC shares rose 1.53% despite broader market weakness.

Chemours, DuPont, and Corteva agreed to a $455M settlement with NC localities over PFAS contamination. Chemours will pay $180M, with funds allocated for mitigation and local governments. The settlement addresses damages from chemical discharge and firefighter exposure, with Chemours committing to future cleanup obligations.

Chemours, DuPont, and Corteva agreed to pay $455M over 15 years to settle PFAS pollution claims in North Carolina, with Chemours covering half. The deal requires court approval. This follows a pattern of settlements by the companies, including a $1.185B national fund for water utilities and a $875M agreement with New Jersey. 3M has also settled similar claims, including a $12.5B national deal. Finalization depends on court dismissal of lawsuits.

North Carolina settled with Chemours, DuPont, and Corteva for $500M over PFAS contamination in water sources. Chemours' Fayetteville facility was found to have released chemicals into the Cape Fear River, affecting 500,000 people. Most funds will go to 11 affected municipalities, with DuPont covering cleanup if Chemours goes bankrupt.

Chemours, DuPont, and Corteva agreed to pay $455 million to resolve PFAS pollution lawsuits in North Carolina, with payments spread over 15 years. Chemours will cover half, while DuPont and Corteva will share the remainder. The settlement includes $18 million for PFAS claims unrelated to the Fayetteville Works plant. The agreement does not end all potential PFAS litigation.

Corteva and partners will pay $455M to North Carolina over 15 years to resolve PFAS claims, with Corteva's share at $66M. Corteva and DuPont guarantee Chemours' payments and must establish a reserve fund. The settlement caps Corteva's legal exposure and preserves its qualified spend capacity for future deals, pending final court approval.